share_log

亿帆医药(002019.SZ):全资子公司法莫替丁注射液获得药品注册证书

Yifan Pharmaceutical (002019.SZ): Wholly-owned subsidiary Famosi Injection receives pharmaceutical registration certificate.

Gelonghui Finance ·  Sep 18 06:19

Yifan Pharmaceutical (002019.SZ) announced on September 18 that its wholly-owned subsidiary, Hefei Yifan Biopharmaceutical Co., Ltd., has recently received the "Drug Registration Certificate" for Famotidine Injection issued by the National Medical Products Administration. Famotidine Injection is mainly used for upper gastrointestinal bleeding caused by peptic ulcers, as well as gastric and duodenal mucosal erosion bleeding caused by various reasons other than tumors and esophageal and gastric fundus varices.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment